spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gruber, P. J.
Right arrow Articles by Chien, K. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gruber, P. J.
Right arrow Articles by Chien, K. R.

Development, Vol 125, Issue 22 4427-4438, Copyright © 1998 by Company of Biologists

JOURNAL ARTICLES

Downregulation of atrial markers during cardiac chamber morphogenesis is irreversible in murine embryos

PJ Gruber, SW Kubalak and KR Chien
Department of Medicine, Center for Molecular Genetics, and the American Heart Association-Bugher Foundation Center for Molecular Biology, University of California, San Diego, La Jolla, California 92093-0613, USA.

Vertebrate cardiogenesis is a complex process involving multiple, distinct tissue types which interact to form a four-chambered heart. Molecules have been identified whose expression patterns co-segregate with the maturation of the atrial and ventricular muscle cell lineages. It is not currently known what role intrinsic events versus external influences play in cardiac chamber morphogenesis. We developed novel, fluorescent-based, myocardial, cellular transplantation systems in order to study these questions in murine embryos and report the irreversible nature of chamber specification with respect to the downregulation of atrial myosin light chain 2 (MLC-2a) and alpha myosin heavy chain (alpha-MHC). Grafting ventricular cells into the atrial chamber does not result in upregulation of MLC-2a expression in ventricular cells. Additionally, wild-type ventricular muscle cells grafted into the wild-type background appropriately downregulate MLC-2a and alpha-MHC. Finally, grafting of RXRalpha gene-deficient ventricular muscle cells into the ventricular chambers of wild-type embryos does not rescue the persistent expression of MLC-2a, providing further evidence that ventricular chamber maturation is an early event. These studies provide a new approach for the mechanistic dissection of critical signaling events during cardiac chamber growth, maturation and morphogenesis in the mouse, and should find utility with other approaches of cellular transplantation in murine embryos. These experiments document the irreversible nature of the downregulation of atrial markers after the onset of cardiogenesis during ventricular chamber morphogenesis and temporally define the response of cardiac muscle cells to signals regulating chamber specification.


This article has been cited by other articles:


Home page
 J. Cell Sci.Home page
R. G. Kelly, M. Lemonnier, S. Zaffran, A. Munk, and M. E. Buckingham
Cell history determines the maintenance of transcriptional differences between left and right ventricular cardiomyocytes in the developing mouse heart
J. Cell Sci., December 15, 2003; 116(24): 5005 - 5013.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
A. F. M. MOORMAN and V. M. CHRISTOFFELS
Cardiac Chamber Formation: Development, Genes, and Evolution
Physiol Rev, October 1, 2003; 83(4): 1223 - 1267.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
J. Li, M. Puceat, C. Perez-Terzic, A. Mery, K. Nakamura, M. Michalak, K.-H. Krause, and M. E. Jaconi
Calreticulin reveals a critical Ca2+ checkpoint in cardiac myofibrillogenesis
J. Cell Biol., July 8, 2002; 158(1): 103 - 113.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
S. W. Kubalak, D. R. Hutson, K. K. Scott, and R. A. Shannon
Elevated transforming growth factor {beta}2 enhances apoptosis and contributes to abnormal outflow tract and aortic sac development in retinoic X receptor {alpha} knockout embryos
Development, January 2, 2002; 129(3): 733 - 746.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
B. G. Bruneau, Z.-Z. Bao, D. Fatkin, J. Xavier-Neto, D. Georgakopoulos, C. T. Maguire, C. I. Berul, D. A. Kass, M. L. Kuroski-de Bold, A. J. de Bold, et al.
Cardiomyopathy in Irx4-Deficient Mice Is Preceded by Abnormal Ventricular Gene Expression
Mol. Cell. Biol., March 1, 2001; 21(5): 1730 - 1736.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
C. M. Hertig, S. W. Kubalak, Y. Wang, and K. R. Chien
Synergistic Roles of Neuregulin-1 and Insulin-like Growth Factor-I in Activation of the Phosphatidylinositol 3-Kinase Pathway and Cardiac Chamber Morphogenesis
J. Biol. Chem., December 24, 1999; 274(52): 37362 - 37369.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
Z. Bao, B. G. Bruneau, J. G. Seidman, C. E. Seidman, and C. L. Cepko
Regulation of Chamber-Specific Gene Expression in the Developing Heart by Irx4
Science, February 19, 1999; 283(5405): 1161 - 1164.
[Abstract] [Full Text]


© The Company of Biologists Ltd 1998